Propanc Biopharma said it will build a crypto treasury after securing up to $100 million from Hexstone Capital to further its potential cancer treatment and reignite investor interest. Australia-based Propanc Biopharma has announced that it has secured $100 million from a crypto-focused family office to launch a crypto treasury — a move its CEO described as “transformative” as its cancer therapy product enters human trials next year. The private placement, structured through convertible preferred stock, provides Propanc with an initial $1 million investment and up to $99 million in follow-on funding over the next 12 months from Hexstone Capital, a family office that invests in several crypto treasury companies.The cancer-treating biotech company stated that the proceeds will be used to build a digital asset treasury and accelerate the development of its lead cancer therapy, PRP, which aims to enter first-in-human trials in the second half of 2026.Read more Propanc Biopharma said it will build a crypto treasury after securing up to $100 million from Hexstone Capital to further its potential cancer treatment and reignite investor interest. Australia-based Propanc Biopharma has announced that it has secured $100 million from a crypto-focused family office to launch a crypto treasury — a move its CEO described as “transformative” as its cancer therapy product enters human trials next year. The private placement, structured through convertible preferred stock, provides Propanc with an initial $1 million investment and up to $99 million in follow-on funding over the next 12 months from Hexstone Capital, a family office that invests in several crypto treasury companies.The cancer-treating biotech company stated that the proceeds will be used to build a digital asset treasury and accelerate the development of its lead cancer therapy, PRP, which aims to enter first-in-human trials in the second half of 2026.Read more

Biopharma raises $100M for crypto treasury to back cancer treatment

2025/11/11 07:24

Propanc Biopharma said it will build a crypto treasury after securing up to $100 million from Hexstone Capital to further its potential cancer treatment and reignite investor interest.

Australia-based Propanc Biopharma has announced that it has secured $100 million from a crypto-focused family office to launch a crypto treasury — a move its CEO described as “transformative” as its cancer therapy product enters human trials next year. 

The private placement, structured through convertible preferred stock, provides Propanc with an initial $1 million investment and up to $99 million in follow-on funding over the next 12 months from Hexstone Capital, a family office that invests in several crypto treasury companies.

The cancer-treating biotech company stated that the proceeds will be used to build a digital asset treasury and accelerate the development of its lead cancer therapy, PRP, which aims to enter first-in-human trials in the second half of 2026.

Read more

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

QB Depth Chart And Injury Updates

QB Depth Chart And Injury Updates

The post QB Depth Chart And Injury Updates appeared on BitcoinEthereumNews.com. COLUMBIA, SOUTH CAROLINA – SEPTEMBER 13: LaNorris Sellers #16 of the South Carolina Gamecocks in action during the game against the Vanderbilt Commodores at Williams-Brice Stadium on September 13, 2025 in Columbia, South Carolina. (Photo by Brendan Ross/Vanderbilt University/University Images via Getty Images) University Images via Getty Images No player moves the college football betting line quite like the quarterback. The best can be worth more than a touchdown compared to the backup, and here’s a look at some of the notable Power 4 QB depth chart and injury updates heading into Week 4. Garrett Nussmeier LSU Tigers QB Garrett Nussmeier has been slowed by a torso injury, head coach Brian Kelly said. He does not appear to be in any danger of missing Saturday’s game against Southeastern Louisiana, but the Tigers should be able to cruise with or without Nussmeier. After tough games against the Clemson Tigers and Florida Gators already, this could be a great opportunity to limit his workload if LSU builds a big lead. If that happens, look for Mississippi State transfer Michael Van Buren to make his Tigers debut. Austin Simmons Ole Miss Rebels QB Austin Simmons reaggravated his left ankle injury in last weekend’s win over the Arkansas Razorbacks. He originally suffered the injury the previous game and did not start but entered when backup Trinidad Chambliss briefly exited. Head coach Lane Kiffin said he anticipates Simmons will start on Saturday against Tulane. If not, Chambliss is likely in line for his second consecutive start. LaNorris Sellers South Carolina Gamecocks QB LaNorris Sellers is listed as questionable on the SEC Availability Report heading into Saturday’s road matchup against the Missouri Tigers. Head coach Shane Beamer declined to say whether he suffered a concussion last weekend against the Vanderbilt Commodores but said he’s optimistic Sellers…
Share
BitcoinEthereumNews2025/09/19 05:17